Emerging evidence suggests that the treatment of UC may positively influence the outcomes of PD, supporting the hypothesis that both conditions share common immunoinflammatory pathways. UC patients undergoing anti-TNF biologic therapy have shown notable improvement in apical periodontitis, with faster healing compared to untreated controls (30). This evidence concerns the gene TNF and periapical periodontitis.